Literature DB >> 25172322

Tumor cells are dislodged into the pulmonary vein during lobectomy.

Xiaosai Yao1, Christina Williamson2, Viktor A Adalsteinsson3, Richard S D'Agostino2, Torin Fitton2, Gregory G Smaroff2, Robert T William4, K Dane Wittrup5, J Christopher Love6.   

Abstract

OBJECTIVE: Intraoperative tumor shedding may facilitate tumor dissemination. In earlier studies, shed tumor cells were defined primarily by cytomorphological examination, and normal epithelial cells could not always be distinguished from tumor cells. We sought to accurately identify tumor cells using single-cell sequencing and determine whether these cells were mobilized into the circulation during pulmonary lobectomy.
METHODS: Forty-two blood samples collected from the tumor-draining pulmonary vein at the end of lobectomy procedures were analyzed. Arrays of nanowells were used to enumerate and retrieve single EpCAM(+) cells. Targeted sequencing of 10 to 15 cells and nested polymerase chain reaction of single cells detected somatic mutations in shed epithelial cells consistent with patient-matched tumor but not normal tissue.
RESULTS: The mean number of EpCAM(+) cells in video-assisted thoracoscopy (VATS) lobectomy (no wedge) specimens (n = 16) was 165 (median, 115; range, 0-509) but sampling cells from 3 patients indicated that only 0% to 38% of the EpCAM(+) cells were tumor cells. The mean number of EpCAM(+) cells in VATS lobectomy (wedge) specimens (n = 12) was 1128 (median, 197; range, 47-9406) and all of the EpCAM(+) cells were normal epithelial cells in 2 patients sampled. The mean number of EpCAM(+) cells in thoracotomy specimens (n = 14) was 238 (median, 22; range, 9-2920) and 0% to 50% of total EpCAM(+) cells were tumor cells based on 4 patients sampled.
CONCLUSIONS: Surgery mobilizes tumor cells into the pulmonary vein, along with many normal epithelial cells. EpCAM alone cannot differentiate between normal and tumor cells. On the other hand, single-cell genetic approaches with patient-matched normal and tumor tissues can accurately quantify the number of shed tumor cells.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172322      PMCID: PMC4356533          DOI: 10.1016/j.jtcvs.2014.06.074

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  A microengraving method for rapid selection of single cells producing antigen-specific antibodies.

Authors:  J Christopher Love; Jehnna L Ronan; Gijsbert M Grotenbreg; Annemarthe G van der Veen; Hidde L Ploegh
Journal:  Nat Biotechnol       Date:  2006-05-14       Impact factor: 54.908

Review 2.  Single-cell sequencing-based technologies will revolutionize whole-organism science.

Authors:  Ehud Shapiro; Tamir Biezuner; Sten Linnarsson
Journal:  Nat Rev Genet       Date:  2013-07-30       Impact factor: 53.242

3.  The effect of intraoperative rectal washout on local recurrence after rectal cancer surgery: a meta-analysis.

Authors:  Akihisa Matsuda; Taro Kishi; Giovanna Musso; Takeshi Matsutani; Kimiyoshi Yokoi; Ping Wang; Eiji Uchida
Journal:  Ann Surg Oncol       Date:  2012-09-18       Impact factor: 5.344

4.  Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.

Authors:  Moritz Koch; Peter Kienle; Ulf Hinz; Dalibor Antolovic; Jan Schmidt; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction.

Authors:  D C Brown; A D Purushotham; G D Birnie; W D George
Journal:  Surgery       Date:  1995-01       Impact factor: 3.982

6.  Tumor cells in blood shed from the surgical field.

Authors:  E Hansen; N Wolff; R Knuechel; J Ruschoff; F Hofstaedter; K Taeger
Journal:  Arch Surg       Date:  1995-04

Review 7.  Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy.

Authors:  Bryan A Whitson; Shawn S Groth; Susan J Duval; Scott J Swanson; Michael A Maddaus
Journal:  Ann Thorac Surg       Date:  2008-12       Impact factor: 4.330

8.  No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression.

Authors:  Daniel Förnvik; Ingvar Andersson; Magnus Dustler; Roy Ehrnström; Lisa Rydén; Anders Tingberg; Sophia Zackrisson; Kristina Aaltonen
Journal:  Breast Cancer Res Treat       Date:  2013-08-29       Impact factor: 4.872

9.  Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.

Authors:  Jens G Lohr; Viktor A Adalsteinsson; Kristian Cibulskis; Atish D Choudhury; Mara Rosenberg; Peter Cruz-Gordillo; Joshua M Francis; Cheng-Zhong Zhang; Alex K Shalek; Rahul Satija; John J Trombetta; Diana Lu; Naren Tallapragada; Narmin Tahirova; Sora Kim; Brendan Blumenstiel; Carrie Sougnez; Alarice Lowe; Bang Wong; Daniel Auclair; Eliezer M Van Allen; Mari Nakabayashi; Rosina T Lis; Gwo-Shu M Lee; Tiantian Li; Matthew S Chabot; Amy Ly; Mary-Ellen Taplin; Thomas E Clancy; Massimo Loda; Aviv Regev; Matthew Meyerson; William C Hahn; Philip W Kantoff; Todd R Golub; Gad Getz; Jesse S Boehm; J Christopher Love
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

10.  Effects of different sequences of pulmonary artery and vein ligations during pulmonary lobectomy on blood micrometastasis of non-small cell lung cancer.

Authors:  Ping-Ping Song; Weidi Zhang; Baijiang Zhang; Qi Liu; Jiajun DU
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

View more
  12 in total

1.  Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective study.

Authors:  Noriyuki Matsutani; Noriyoshi Sawabata; Masafumi Yamaguchi; Tetsukan Woo; Yujin Kudo; Akikazu Kawase; Satoshi Shiono; Hisae Iinuma; Shigeki Morita; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?

Authors:  Noriyoshi Sawabata; Soichiro Funaki; Takeru Hyakutake; Yasushi Shintani; Ayako Fujiwara; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-03-07       Impact factor: 2.549

3.  Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.

Authors:  Mario Mascalchi; Massimo Falchini; Cristina Maddau; Francesca Salvianti; Marco Nistri; Elena Bertelli; Lapo Sali; Stefania Zuccherelli; Alessandra Vella; Marzia Matucci; Luca Voltolini; Andrea Lopes Pegna; Michaela Luconi; Pamela Pinzani; Mario Pazzagli
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-26       Impact factor: 4.553

4.  Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.

Authors:  Chien-Sheng Huang; Hung-Che Chien; Chun-Ku Chen; Yi-Chen Yeh; Po-Kuei Hsu; Hui-Shan Chen; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang; Chun-Che Shih
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

5.  Perioperative detection of circulating tumour cells in patients with lung cancer.

Authors:  Dimple Chudasama; Nathan Burnside; Julie Beeson; Emmanouil Karteris; Alexandra Rice; Vladimir Anikin
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

6.  Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.

Authors:  Mario Mascalchi; Cristina Maddau; Lapo Sali; Elena Bertelli; Francesca Salvianti; Stefania Zuccherelli; Marzia Matucci; Alessandra Borgheresi; Claudio Raspanti; Monica Lanzetta; Massimo Falchini; Ernesto Mazza; Alessandra Vella; Michaela Luconi; Pamela Pinzani; Mario Pazzagli
Journal:  J Cancer       Date:  2017-07-15       Impact factor: 4.207

7.  Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection.

Authors:  Stefanie S Jeffrey; Elodie Sollier-Christen; Haiyan E Liu; Melanie Triboulet; Amin Zia; Meghah Vuppalapaty; Evelyn Kidess-Sigal; John Coller; Vanita S Natu; Vida Shokoohi; James Che; Corinne Renier; Natalie H Chan; Violet R Hanft
Journal:  NPJ Genom Med       Date:  2017-11-01       Impact factor: 8.617

8.  Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.

Authors:  Masaki Hashimoto; Fumihiro Tanaka; Kazue Yoneda; Teruhisa Takuwa; Seiji Matsumoto; Yoshitomo Okumura; Nobuyuki Kondo; Tohru Tsujimura; Takashi Nakano; Seiki Hasegawa
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

9.  Single-cell chromatin accessibility landscape of human umbilical cord blood in trisomy 18 syndrome.

Authors:  Xiaofen Qiu; Haiyan Yu; Hongwei Wu; Zhiyang Hu; Jun Zhou; Hua Lin; Wen Xue; Wanxia Cai; Jiejing Chen; Qiang Yan; Weier Dai; Ming Yang; Donge Tang; Yong Dai
Journal:  Hum Genomics       Date:  2021-06-30       Impact factor: 4.639

10.  Automated rare single cell picking with the ALS cellcelector™.

Authors:  Constantin Nelep; Jens Eberhardt
Journal:  Cytometry A       Date:  2018-09-05       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.